Tag: White House appointment

White House appointment

Regulatory/FDA

Sharpless to Succeed Gottlieb at FDA on Acting Basis

Sharpless to Succeed Gottlieb at FDA on Acting Basis

March 13, 2019 — The Trump administration wasted little time in appointing an acting FDA Commissioner: Dr. Norman (Ned) Sharpless – currently director of the National Cancer Institute – has been tapped to succeed Dr. Scott Gottlieb (who resigned March 5) on a temporary basis. Sharpless is a physician and former director of the Lineberger […]

Read more

Categories

Recent Posts

Tags

ad tax Advertising Coalition CDER CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media free speech gifts to physicians HHS John Kamp Jon Bigelow kamp Kate Rawson legislation litigation marketing off-label off-label communication omission of risk OPDP OPDP enforcement PhRMA regulation Risk Information rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines